BioShares Biotechnology Risk Analysis

BioShares Biotechnology Products -- USA Etf  

USD 41.29  0.58  1.42%

We consider BioShares Biotechnology not too risky. BioShares Biotechnology secures Sharpe Ratio (or Efficiency) of 0.1765 which signifies that BioShares Biotechnology had 0.1765% of return per unit of risk over the last 1 month. Our philosophy towards foreseeing volatility of a etf is to use all available market data together with company specific technical indicators that cannot be diversified away. We have found twenty-one technical indicators for BioShares Biotechnology Products which you can use to evaluate future volatility of the entity. Please confirm BioShares Biotechnology Downside Deviation of 1.32, Risk Adjusted Performance of 0.0792 and Mean Deviation of 0.8076 to double-check if risk estimate we provide are consistent with the epected return of 0.1947%.
 Time Horizon     30 Days    Login   to change

BioShares Biotechnology Market Sensitivity

One Month Beta |Analyze BioShares Biotechnology Demand Trend
Check current 30 days BioShares Biotechnology correlation with market (DOW)
β = -1.0051
BioShares Biotechnology llmost one BetaBioShares Biotechnology Beta Legend

BioShares Biotechnology Technical Analysis

The output start index for this execution was zero with a total number of output elements of seventeen. BioShares Biotechnology Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input. View also all equity analysis or get more info about average price price transform indicator.

Projected Return Density Against Market

Considering 30-days investment horizon, BioShares Biotechnology Products has beta of -1.0051 . This suggests Moreover, BioShares Biotechnology Products has an alpha of 0.4 implying that it can potentially generate 0.4% excess return over DOW after adjusting for the inherited market risk (beta).
 Predicted Return Density 
Considering 30-days investment horizon, the coefficient of variation of BioShares Biotechnology is 566.67. The daily returns are destributed with a variance of 1.22 and standard deviation of 1.1. The mean deviation of BioShares Biotechnology Products is currently at 0.87. For similar time horizon, the selected benchmark (DOW) has volatility of 0.45
Alpha over DOW
Beta against DOW=1.01
Overall volatility
Information ratio =0.07

Actual Return Volatility

BioShares Biotechnology Products has volatility of 1.1035% on return distribution over 30 days investment horizon. DOW inherits 0.4387% risk (volatility on return distribution) over the 30 days horizon.
 Performance (%) 

Market Risk Breakdown

BioShares Biotechnology Volatility Factors

30 Days Market Risk

Not too risky

Chance of Distress in 24 months

Almost imposible

30 Days Economic Sensitivity

Totally opposite to market

Largest Trends

BioShares Biotechnology Largest Period Trend

Investment Outlook

BioShares Biotechnology Investment Opportunity
BioShares Biotechnology Products has a volatility of 1.1 and is 2.5 times more volatile than DOW. 10% of all equities and portfolios are less risky than BioShares Biotechnology. Compared to the overall equity markets, volatility of historical daily returns of BioShares Biotechnology Products is lower than 10 (%) of all global equities and portfolios over the last 30 days. Use BioShares Biotechnology Products to enhance returns of your portfolios. The etf experiences large bullish trend. Check odds of BioShares Biotechnology to be traded at $45.42 in 30 days.

BioShares Biotechnology correlation with market

Very good diversification
Overlapping area represents the amount of risk that can be diversified away by holding BioShares Biotechnology Produc and equity matching DJI index in the same portfolio.

Volatility Indicators

BioShares Biotechnology Current Risk Indicators